Biological
Yellow Fever Vaccine clinical trials
Also written Stamaril and YF-VAX.
- studies test it
- 25
- open now
- 4
- in phase 3
- 8
- first study started
- 2004
Keep track of what changes. Save the Yellow Fever Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2011 (4)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2011 | 4 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 8
- Phase 3
- 8
- Phase 4
- 5
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 14
Sanofi Pasteur, a Sanofi Company (4) · GlaxoSmithKline (3) · Sanofi (2) · PATH (1) · University of Aarhus (1) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1) · US Army Medical Research Institute of Infectious Diseases (1) · Shanghai Institute Of Biological Products (1)
Often tested with
Tested in the same studies.
Measles Vaccine (2) · Rubella Vaccine (2) · Japanese Encephalitis Vaccines (2) · R21 (1) · Vaccines, Combined (1) · Typhoid-Paratyphoid Vaccines (1) · Vitamin A (1) · Diphtheria-Tetanus-Pertussis Vaccine (1)
Studies
Open first, then newest update. How each study uses Yellow Fever Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 25
- Antibiotics and Vaccine Immune Responses StudyRecruitingPhase 4South Australian Health and Medical Research InstituteNCT06148025Written as Yellow Fever vaccine
- Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 MonthsNot yet recruitingPhase 3International Centre for Diarrhoeal Disease Research, BangladeshNCT06815835Written as Yellow fever Vaccine (WHO prequalified)
- Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNot yet recruitingNot applicableANRS, Emerging Infectious DiseasesNCT05450770Written as Yellow fever vaccination (STAMARIL)
- Yellow Fever Human Infection Model With YF-17DRecruitingNot applicableLeiden University Medical CenterNCT05901454Written as Yellow Fever Vaccine
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingPhase 2PATHNCT06879327Written as Yellow Fever vaccine
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsCompletedPhase 2GlaxoSmithKlineNCT06213506Written as Yellow Fever vaccine
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive, not recruitingPhase 2Sanofi Pasteur, a Sanofi CompanyNCT04942210Written as Yellow fever vaccine (produced on serum-free Vero cells)
- Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive, not recruitingPhase 2Sanofi Pasteur, a Sanofi CompanyNCT05011123Written as Yellow fever vaccine (produced on serum-free Vero cells)
- Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever VaccineCompletedPhase 4US Army Medical Research Institute of Infectious DiseasesNCT05374317Written as Yellow Fever Vaccine
- Phase 3 Single Arm, Open Study on vYF in AdultsCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT07222059Written as Yellow fever vaccine (live)
- Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsCompletedPhase 3SanofiNCT07002060Written as Yellow fever vaccine (live)
- Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 MonthsCompletedPhase 3Shanghai Institute Of Biological ProductsNCT06399003Written as Yellow Fever Vaccine (Stamaril)
- The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationCompletedPhase 1/2University of MinnesotaNCT04269265Written as Yellow Fever Vaccine
- Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever VaccineCompletedPhase 4Sri EdupugantiNCT01290055Written as Yellow fever vaccine
- Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D VaccinationActive, not recruitingPhase 4University of AarhusNCT04083430Written as Yellow Fever Vaccine
- Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)Active, not recruitingPhase 4The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)NCT02555072Written as yellow fever vaccine
- Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT01436396Written as Yellow fever vaccine
- Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.CompletedPhase 3GlaxoSmithKlineNCT02699099Written as Stamaril
- Yellow Fever Vaccine on Statin/ Non Statin SubjectsCompletedPhase 2Singapore General HospitalNCT03116802Written as Stamaril (live attenuated yellow fever vaccine)
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedPhase 2GlaxoSmithKlineNCT01262872Written as Stamaril™
See all 25 studies that test Yellow Fever Vaccine →
Given in every arm · 9 — Yellow Fever Vaccine is usual care beside what is tested
- A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationRecruitingPhase 3SanofiNCT07103148Written as Yellow fever vaccine (live)
- Improving Vaccine Protection for AdultsRecruitingPhase 2Singapore General HospitalNCT07527247Written as YF17D (Stamaril, Sanofi-Pasteur)
- An Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityRecruitingPhase 2Singapore General HospitalNCT05568953Written as Stamaril
- Human Immune Responses to Yellow Fever VaccinationCompletedPhase 4Emory UniversityNCT00694655Written as Yellow Fever Vaccine
- Coadministration of GA2 Sporozoites With AdjuvantsStatus unknownEarly Phase 1Leiden University Medical CenterNCT05468606Written as YF-17D (fractional ID dose)
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedPhase 3GlaxoSmithKlineNCT01345240Written as Yellow fever vaccine
- Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliCompletedPhase 4PATHNCT02286895Written as yellow fever vaccine (YFV)
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedPhase 2GlaxoSmithKlineNCT00436007Written as Stamaril™
- The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansCompletedPhase 2Singapore General HospitalNCT01943305Written as Yellow Fever vaccine
As the comparator · 3 — what is tested is compared with Yellow Fever Vaccine
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy InfantsRecruitingPhase 3Serum Institute of India Pvt. Ltd.NCT05447377Written as STAMARIL®
- Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsCompletedPhase 1Sanofi Pasteur, a Sanofi CompanyNCT04142086Written as Yellow fever vaccine
- A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARILCompletedPhase 3Serum Institute of India Pvt. Ltd.NCT05421611Written as STAMARIL
Codes
What other systems call Yellow Fever Vaccine · ClinicalTrials.gg INT008793
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D022341 | Yellow Fever Vaccine | One source ClinicalTrials.gov |
| RxNorm | 804187 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.